Zaurategrast (CDP323) is a small-molecule prodrug antagonist that inhibits the interaction between vascular cell adhesion molecule 1 (VCAM-1) and alpha4-integrins, originally developed by Celltech plc for oral administration, and it serves as a valuable research compound for investigating leukocyte trafficking, immune cell adhesion, and therapeutic strategies relevant to multiple sclerosis.
Molecular Weight:
521.41
CAS Number:
[455264-31-0]
Formula:
C26H25BrN4O3
Target:
Integrin
T17286
T17286
* VAT and and shipping costs not included. Errors and price changes excepted